Lv4
458 积分 2023-10-26 加入
PGV001, a Multi-Peptide Personalized Neoantigen Vaccine Platform: Phase I Study in Patients with Solid and Hematologic Malignancies in the Adjuvant Setting
4小时前
已完结
A shared neoantigen vaccine combined with immune checkpoint blockade for advanced metastatic solid tumors: phase 1 trial interim results
4小时前
已完结
Nasopharyngeal carcinoma
4天前
已完结
Epidemiology of nasopharyngeal carcinoma: current insights and future outlook
4天前
已完结
Therapeutic cancer vaccines
7天前
已完结
Neoantigen-driven cancer vaccines in personalized oncology: progress, obstacles, and translational prospects
10天前
已完结
Cancer vaccines: the next immunotherapy frontier
11天前
已完结
Reconsidering adjuvant and perioperative immune-checkpoint inhibition: de-escalation, expansion and personalization
11天前
已完结
Perioperative Immunotherapy — A KEY toward Improved Outcomes for Early-Stage Lung Cancer?
11天前
已完结
Cell-intrinsic and microenvironmental determinants of metastatic colonization
12天前
已完结
皖公网安备34019202002308
